Extracranial stereotactic radioablation. Review of biological basis, technique and preliminary clinical experience

Higinia Cardenes, R. Timmerman, L. Papiez

Research output: Contribution to journalReview article

7 Scopus citations

Abstract

Extracranial stereotactic radioablation (ESR) is a new and exiting treatment modality of delivering high dose, hypofractionated irradiation, to extracranial tumors. In the present article we will briefly review the rationale, biological implications of "extreme" hypofractionation, treatment technique and published data. In addition data from an ongoing Phase I clinical trial in patients with clinical stage I, medically inoperable, non-small cell lung cancer, conducted at Indiana University will be presented.

Original languageEnglish (US)
Pages (from-to)19-25+i
JournalOncologia
Volume25
Issue number4
StatePublished - Jan 1 2002

Keywords

  • Biological basis
  • Clinical experience
  • Extracranial
  • Stereotactic radioablation

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Extracranial stereotactic radioablation. Review of biological basis, technique and preliminary clinical experience'. Together they form a unique fingerprint.

  • Cite this